| Reference |
|---|
Nunes Santos C, Kuehn H, Boast B, Hwang S, Kuhns D, Stoddard J, et al. Inherited ARPC5 mutations cause an actinopathy impairing cell motility and disrupting cytokine signaling. Nat Commun. 2023;14:3708 pubmed publisher |
He T, Ling N, Zhang G, Xiang D, Hu P, Peng M, et al. Decreased antibody response to influenza vaccine with an enhanced antibody response to subsequent SARS-CoV-2 vaccination in patients with chronic hepatitis B virus infection. Immun Inflamm Dis. 2023;11:e759 pubmed publisher |
Braham M, van Binnendijk R, Buisman A, Mebius R, de Wit J, van Els C. A synthetic human 3D in vitro lymphoid model enhancing B-cell survival and functional differentiation. iScience. 2023;26:105741 pubmed publisher |
Marzan Rivera N, Serrano Collazo C, Cruz L, Pantoja P, Ortiz Rosa A, Arana T, et al. Infection order outweighs the role of CD4+ T cells in tertiary flavivirus exposure. iScience. 2022;25:104764 pubmed publisher |
Lende S, Pahus M, Monrad I, Olesen R, Mahr A, Vibholm L, et al. CD169 (Siglec-1) as a Robust Human Cell Biomarker of Toll-Like Receptor 9 Agonist Immunotherapy. Front Cell Infect Microbiol. 2022;12:919097 pubmed publisher |
Gupta R, Vanlieshout E, Manion K, Bonilla D, Kim M, Mu xf1 oz Grajales C, et al. Altered Balance of Pro-Inflammatory Immune Cells to T Regulatory Cells Differentiates Symptomatic From Asymptomatic Individuals With Anti-Nuclear Antibodies. Front Immunol. 2022;13:886442 pubmed publisher |
Campisi L, Chizari S, Ho J, Gromova A, Arnold F, Mosca L, et al. Clonally expanded CD8 T cells characterize amyotrophic lateral sclerosis-4. Nature. 2022;606:945-952 pubmed publisher |
Harris M, Fuyal M, James J. Quantifying persistence in the T-cell signaling network using an optically controllable antigen receptor. Mol Syst Biol. 2021;17:e10091 pubmed publisher |
Solforosi L, Kuipers H, Jongeneelen M, Rosendahl Huber S, van der Lubbe J, Dekking L, et al. Immunogenicity and efficacy of one and two doses of Ad26.COV2.S COVID vaccine in adult and aged NHP. J Exp Med. 2021;218: pubmed publisher |
Routhu N, Cheedarla N, Gangadhara S, Bollimpelli V, Boddapati A, Shiferaw A, et al. A modified vaccinia Ankara vector-based vaccine protects macaques from SARS-CoV-2 infection, immune pathology, and dysfunction in the lungs. Immunity. 2021;54:542-556.e9 pubmed publisher |
Vierboom M, Dijkman K, Sombroek C, Hofman S, Boot C, Vervenne R, et al. Stronger induction of trained immunity by mucosal BCG or MTBVAC vaccination compared to standard intradermal vaccination. Cell Rep Med. 2021;2:100185 pubmed publisher |
Jegaskanda S, Andrews S, Wheatley A, Yewdell J, McDermott A, Subbarao K. Hemagglutinin head-specific responses dominate over stem-specific responses following prime boost with mismatched vaccines. JCI Insight. 2019;4: pubmed publisher |
Peterson C, Adair J, Wohlfahrt M, Deléage C, Radtke S, Rust B, et al. Autologous, Gene-Modified Hematopoietic Stem and Progenitor Cells Repopulate the Central Nervous System with Distinct Clonal Variants. Stem Cell Reports. 2019;: pubmed publisher |
Heger L, Balk S, Lühr J, Heidkamp G, Lehmann C, Hatscher L, et al. CLEC10A Is a Specific Marker for Human CD1c+ Dendritic Cells and Enhances Their Toll-Like Receptor 7/8-Induced Cytokine Secretion. Front Immunol. 2018;9:744 pubmed publisher |
Swanstrom A, Haggarty B, Jordan A, Romano J, Leslie G, Aye P, et al. Derivation and Characterization of a CD4-Independent, Non-CD4-Tropic Simian Immunodeficiency Virus. J Virol. 2016;90:4966-4980 pubmed publisher |
